STAT3 and breast carcinoma: Mounting evidence suggests that the JAK/STAT3 signaling pathway plays a key role in tumor metastasis and EMT, with an active IL6/JAK2/STAT3 axis and stem cell‐like characteristics contributing to the poor prognosis of metastasized breast cancers [29].